Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Metadata
Title
Serum levels of IL-10, IL-6, IL-1ra, and sIL-2R in patients with psoriatic arthritis
Authors
O. Elkayam
I. Yaron
I. Shirazi
M. Yaron
D. Caspi
Publication date
01-03-2000
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 3/2000
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s002960050111

Other articles of this Issue 3/2000

Rheumatology International 3/2000 Go to the issue

ORIGINAL ARTICLE

Expression of κ-opioid receptor mRNA in human peripheral blood lymphocytes and the relationship between its expression and the inflammatory changes in rheumatoid arthritis

ORIGINAL ARTICLE

A longitudinal study of autoantibodies against central nervous system tissue and gangliosides in connective tissue diseases

ORIGINAL ARTICLE

Immediate and delayed effects of treatment at the Dead Sea in patients with psoriatic arthritis

ORIGINAL ARTICLE

Rheumatoid factors in systemic lupus erythematosus: association with clinical and laboratory parameters

ORIGINAL ARTICLES

Influence of cyclosporin A on radiological progression in early rheumatoid arthritis patients: a 42-month prospective study

ORIGINAL ARTICLE

Spondylitis is the most common pattern of psoriatic arthritis in Korea

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits